Cboe UK • GBp PureTech Health plc (PRTCL.XC) Follow Add holdings 134.30 +0.70 +(0.52%) At close: May 23 at 4:28:21 PM GMT+1 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for PRTCL.XC 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: PRTCL.XC View More All News Press Releases SEC Filings PureTech to Present at the Jefferies Global Healthcare Conference PureTech’s Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial PureTech Announces Publication of New Research Highlighting Untold Experiences of People Living with Idiopathic Pulmonary Fibrosis (IPF) Shareholders In PureTech Health (LON:PRTC) Should Look Beyond Earnings For The Full Story PureTech Health PLC (PTCHF) (FY 2024) Earnings Call Highlights: Strong Financial Execution and ... PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference PureTech Announces Annual Results for Year Ended December 31, 2024 PureTech Health: Notice of Results PureTech Appoints Peel Hunt as Joint UK Corporate Broker PureTech Health plc Statement Regarding Press Speculation PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair